Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 03 2020 - 08:01AM
Business Wire
Endologix, Inc. (Nasdaq: ELGX) (the “Company”), a developer and
marketer of innovative treatments for aortic disorders, announced
today the grant of an inducement equity award to a newly hired
employee (the “Awardee”). The award was approved by the Company’s
Compensation Committee, which is comprised of independent
directors, on December 6, 2019 as an inducement material to the
Awardee’s entry into employment with the Company, as permitted
under NASDAQ Listing Rule 5635(c)(4).
The inducement grant to the Awardee consists of restricted stock
unit (“RSU”) awards. An aggregate of up to 29,762 shares of the
Company’s common stock, par value $0.001 per share (“Common
Stock”), are issuable upon settlement of the RSUs. The grant date
for the RSUs was December 30, 2019. The issuance price of the RSUs
are equal to the closing price per share of Common Stock, as
reported by NASDAQ, on December 30, 2019.
One-third (33%) of the shares subject to the RSUs will vest on
each anniversary of the grant date, subject to tenure
requirements.
About Endologix
Endologix, Inc. develops, manufactures, markets and sells
innovative medical devices for the treatment of aortic disorders.
The Company's products are intended for the minimally invasive
endovascular treatment of abdominal aortic aneurysms (“AAA”). AAA
occurs when a portion of the abdominal aorta bulges into an
aneurysm because of a weakening of the vessel wall, which may
result in life threatening internal bleeding upon rupture. The
overall patient mortality rate for ruptured AAA is approximately
80%, making it among the leading causes of death in the United
States. For more information, visit www.endologix.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200203005189/en/
INVESTORS: Endologix, Inc. Vaseem Mahboob, CFO (949)
595-7200
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Mar 2023 to Mar 2024